Showing results (1-10 of 218) with videos related to
Sort By:
Pageof 22
Current Opinion in Rheumatology|January 1, 2014
Prospects for therapeutic tolerance in humansKenneth F Baker, John D IsaacsAnnals of the Rheumatic Diseases|August 3, 2017
Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?Kenneth F Baker, John D IsaacsBMC Rheumatology|June 22, 2019
"Living a normal life": a qualitative study of patients' views of medication withdrawal in rheumatoid arthritisKenneth F Baker, John D Isaacs, Ben ThompsonThe Lancet. Rheumatology|January 27, 2024
Biomarkers of tolerance in immune-mediated inflammatory diseases: a new era in clinical management?Kenneth F Baker, Jasmine P X Sim, John D IsaacsTherapeutic Advances in Musculoskeletal Disease|June 12, 2020
Lack of association between clinical and ultrasound measures of disease activity in rheumatoid arthritis remissionKenneth F Baker, Ben Thompson, Dennis W Lendrem, et al.Journal of Autoimmunity|July 9, 2019
Predicting drug-free remission in rheumatoid arthritis: A prospective interventional cohort studyKenneth F Baker, Andrew J Skelton, Dennis W Lendrem, et al.Nature Reviews. Immunology|July 24, 2010
The changing face of rheumatoid arthritis: sustained remission for all?John D IsaacsExpert Opinion on Biological Therapy|November 18, 2009
Therapeutic agents for patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor-alpha antagonistsJohn D IsaacsCurrent Opinion in Pharmacology|July 6, 2007
T cell immunomodulation--the Holy Grail of therapeutic toleranceJohn D IsaacsArthritis Research & Therapy|June 4, 2009
Antibody engineering to develop new antirheumatic therapiesJohn D IsaacsPageof 22